Neuropharmacology & Brain Health
Neuropharmacology & Brain Health
Exploring the mechanisms of brain function and dysfunction to develop therapies for neurological and psychiatric disorders.
Research in this theme spans neurodegeneration, stroke, stress-related disorders, and the gut-brain axis, using cutting-edge models and translational approaches.
Researchers:
- Prof. Aideen Sullivan (Parkinson’s disease, neurotrophic therapies)
- Dr. Barry Boland (lysosomal flux in Alzheimer’s)
- Prof. Christian Waeber (stroke, neuroprotection)
- Dr. Rachel Moloney (PTSD, stress neurobiology)
- Dr. Jatin Nagpal (microbiome and social behaviour in zebrafish)
- Dr. Linda Katona (GABAergic circuits and schizophrenia)
- Dr. Friederike Uhlig (gut-brain signalling in GI disorders)